4//SEC Filing
Kuhlmann Shirley R. 4
Accession 0001062993-25-004776
CIK 0001267565other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 6:48 PM ET
Size
11.9 KB
Accession
0001062993-25-004776
Insider Transaction Report
Form 4
Kuhlmann Shirley R.
EVP and General Counsel
Transactions
- Exercise/Conversion
Stock Option (Right to Purchase)
2025-03-04−40,000→ 0 totalExercise: $24.03Exp: 2028-04-04→ Common Stock (40,000 underlying) - Exercise/Conversion
Common Stock
2025-03-04$24.03/sh+40,000$961,200→ 194,204 total - Sale
Common Stock
2025-03-04$28.08/sh−40,000$1,123,160→ 154,204 total - Sale
Common Stock
2025-03-05$28.03/sh−20,000$560,528→ 134,204 total - Sale
Common Stock
2025-03-06$28.50/sh−26,067$742,946→ 108,137 total
Footnotes (4)
- [F1]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
- [F2]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.18, inclusive.
- [F3]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.50 to $28.58, inclusive.
- [F4]The option is fully vested and exercisable.
Issuer
COLLEGIUM PHARMACEUTICAL, INC
CIK 0001267565
Entity typeother
Related Parties
1- filerCIK 0001734919
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 6:48 PM ET
- Size
- 11.9 KB